Gumetinib Tablets (trade name: Haiyitan) is a prescription-only medicine that must be used under the guidance of a physician. Based on available infor···【Read More】
Update: 2026-01-26Source: Haiou HealthViews: 83
Gumetinib is a targeted therapy drug indicated for MET gene mutation, primarily used in the treatment of solid tumors such as non-small cell lung canc···【Read More】
Update: 2026-01-26Source: Haiou HealthViews: 75
The storage temperature of Gumetinib is generally required to be controlled within a 2°C to 8°C refrigerated environment. It should be stored away fro···【Read More】
Update: 2026-01-26Source: Haiou HealthViews: 77
Shanghai, China, 14 January 2025 – AstraZeneca today announced that the National Medical Products Administration (NMPA) of China has officially approv···【Read More】
Update: 2026-01-26Source: Haiou HealthViews: 75
On June 23, 2021, the National Medical Products Administration (NMPA) announced the conditional approval of Savolitinib Tablets (trade name: ORPATHYS)···【Read More】
Update: 2026-01-26Source: Haiou HealthViews: 73
No, it cannot. The drug may lose its efficacy and even trigger adverse reactions.【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 82
A light diet is recommended. Avoid spicy and greasy foods, and prioritize easily digestible food items.【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 81
Hello, Savolitinib is a prescription-only medicine. Upon placing an order with a valid prescription, we can provide compliant mailing services to ensu···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 73
The price of Savolitinib is affected by factors including specifications, regions and medical insurance policies. Currently, its market price generall···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 73
Savolitinib is a targeted therapy drug primarily indicated for the treatment of patients with locally advanced or metastatic solid tumors (e.g., non-s···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 88
Savolitinib is a domestically innovative drug independently developed by a Chinese pharmaceutical enterprise. Developed by Hutchmed, it was approved f···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 83
Savolitinib is a targeted therapy drug indicated for the treatment of non-small cell lung cancer (NSCLC) harboring specific gene mutations (e.g., MET ···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 82
During the course of Savolitinib treatment, it is necessary to avoid grapefruit - like fruits, alcohol, and high - fat foods, and adjust your diet in ···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 85
Savolitinib is a targeted therapy primarily indicated for the treatment of specific subtypes of non-small cell lung cancer (NSCLC). Dosing regimens fo···【Read More】
Update: 2026-01-23Source: Haiou HealthViews: 74
Beijing, China, April 25, 2025 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 2026-01-22Source: Haiou HealthViews: 88
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH



